Please assess the completion status of the following clinical trial:

Trial Title: Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Chronological age (CA) between 3 and 10 for girls~* Chronological age between 3 and 12 for boys~* Height for CA below - 2 SD~* Birth length for CA below -2SD~Exclusion Criteria:~* Endocrine disease except well-substituted hypothyroidism~* Sever chronic disease~* Skeletal dysplasia~* Known chromosomal aberration~* Ongoing treatment with steroids~* Known intrauterine infection

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Genotonorm A (Type: ACTIVE_COMPARATOR): Continuous 0.7 IU/kg/week or 0.03 mg/kg/day
- Genotonorm B (Type: ACTIVE_COMPARATOR): Continuous, 1.4 IU/kg/week or 0.06 mg/kg/day
- Genotonorm C (Type: ACTIVE_COMPARATOR): Intermittent, 1.4 IU/kg/week or 0.06 mg/kg/day

Based on this trial design, predict the completion outcome and termination type (if applicable).